In conjunction with its role as a cachexia mediator, IL-1β impairs immune function in multiple ways including the stimulation of myeloid-derived suppressor cells (MDSCs) [35] and the induction of IL-6 and IL-22 expression [36,37]. The gene discussed is IL6; the disease is Cachexia.